RxDoctor Payments Data

Richard Pierson, MD

Surgery · Baltimore, MDNPI 1235152398

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $2,500 of the $2,806 with a category attached, or 89.1%. Modernatx, Inc. accounts for 89.1% of it on its own, with 3 other manufacturers making up the rest.

$2,806in general payments, 2019–2025

Across 6 payments — averaging $467.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Modernatx, Inc.$3K
  • Paragonix Technologies, Inc.$160
  • Veloxis Pharmaceuticals, Inc.$109
  • Abiomed$37
$396,694in research payments, 2019–2025

Across 5 payments — averaging $79,339 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Modernatx, Inc.$397K

What the payments were for

  • Consulting fees$2,50089%
  • Food & beverage$30611%

General payments by program year

22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,806 in reported general payments places this provider in the 60th percentile of 493 surgery providers in Maryland.

See all surgery providers in Maryland

Medicare billing

Part B allowed, 2024
$77,722
Medicare patients
120
Services billed
363

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other surgery in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →